0 Commentarii
0 Distribuiri
219 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Global Biological Safety Testing Products and Services Market to Reach USD 11.93 Billion by 2033, Driven by Rising Biologics and Vaccine DevelopmentThe global biological safety testing products and services market size was valued at USD 4.82 billion in 2024 and is projected to grow from USD 5.33 billion in 2025 to reach USD 11.93 billion by 2033, growing at a CAGR of 10.59% during the forecast period (2025-2033). How Is the Biological Safety Testing Products and Services Market Analyzed and What Research...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Halal Vaccine Development: Meeting Religious and Healthcare Needs in the Modern WorldThe development of vaccines that comply with Islamic dietary laws represents a significant advancement in meeting the healthcare needs of Muslim communities worldwide. Halal vaccine development is a growing area of focus for the pharmaceutical industry, driven by increasing consumer demand for products that align with religious values. The halal vaccine development market is...0 Commentarii 0 Distribuiri 147 Views 0 previzualizare
-
Vaccine Contract Manufacturing Market Outlook Amid Growing Vaccine DevelopmentAccording to a new report by Polaris Market Research, the global vaccine contract manufacturing market was valued at USD 4.61 billion in 2023 and is projected to reach USD 13.16 billion by 2032, expanding at a CAGR of 12.4% over the forecast period. Growth is underpinned by rising global demand for preventive healthcare, expanding biopharmaceutical manufacturing complexity, and...0 Commentarii 0 Distribuiri 189 Views 0 previzualizare
-
Vaccine Development Platforms and Lipid Nanoparticle Delivery: Building a Comprehensive mRNA Vaccine FrameworkThe production of effective mRNA vaccines requires a sophisticated approach that combines advanced vaccine development platforms with effective lipid nanoparticle delivery systems. At the core of this approach are Vaccine Development Platforms , which provide the tools and processes needed for rapid design, manufacturing, and scale-up of mRNA vaccines. The global mRNA vaccines for...0 Commentarii 0 Distribuiri 291 Views 0 previzualizare
-
Viral Vaccine Technologies and Coronavirus Vaccine Development: Building a Comprehensive Pandemic Response FrameworkThe management of pandemic threats requires a sophisticated approach that combines effective viral vaccine technologies with comprehensive coronavirus vaccine development efforts. At the core of this approach are Viral Vaccine Technologies , which provide the platforms and processes needed for rapid, scalable vaccine production. The global novel coronavirus inactivated vaccine market,...0 Commentarii 0 Distribuiri 345 Views 0 previzualizare
-
Herpes Simplex Virus (HSV) Vaccines Market Reaching USD 1,360 Million by 2034According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
North America Inactivated Vaccines Market Trends, Growth Analysis and Industry OutlookNorth America holds a significant share of the inactivated vaccines market due to high vaccination coverage, established healthcare systems, and strong government support for immunization initiatives. Growing awareness of preventive healthcare, continuous vaccine innovation, and increasing efforts to control infectious diseases are expected to support market expansion across the region. The...0 Commentarii 0 Distribuiri 943 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek